Orin
NXNYSE·Construction Materials

Quanex Building Products Corporation NX

Market cap $920.4MP/E 20.0× trailingGross margin 22.7%
$19.83
−0.83 (−4.02%)Wed close 16:00 ET
52-wk $11.04 – $23.33
Watch
Orin's take
0.62conviction · moderate
Refreshed 23 Sep · take v4. A new filing or a print queues the next refresh.

Quanex's Q3 FY2026 results (quarter ended 2026-07-31) validate the post-acquisition turnaround: operating income of $46.5M in the quarter marks a sharp sequential acceleration from $2.9M in Q1 and $18.7M in Q2, and the $0.58 diluted EPS beat consensus of $0.658 by roughly 20%, triggering a 22% one-day stock surge to a 52-week high. The stock still trades at 0.46x P/S — below the peer median of 0.57x — and sits above both its 50-day ($19.90) and 200-day ($18.58) moving averages at $20.66, reflecting improving momentum without excessive valuation stretch.

The core risk is that FY2025 left the balance sheet levered at $854M in total debt with a $251M net loss, so sustained quarterly profitability is needed to de-risk the capital structure.

What could go wrong

  • High leverage from acquisition. Total debt stood at $854M as of FY2025 (ended 2025-10-31), up from $116M in FY2023, creating interest burden and balance-sheet fragility if the turnaround stalls.
  • Volume stagnation. Q3 FY2026 volumes were flat with revenue growth of only 1.3% YoY; pricing gains of ~3% were partially offset by ~2% tariff-revenue reduction, limiting organic top-line upside.
  • Stock already re-rated. Shares surged 22% on September 4, 2026 to a 52-week high, meaning much of the turnaround optimism may now be discounted in the price.
  • Insider net selling. Over the trailing 24 months, insiders net disposed approximately $4.6M in real shares (acquisitions were predominantly phantom stock units tied to compensation), offering no strong insider conviction signal.

What would change my mind

Q4 FY2026 earnings. Operating income continues sequential improvement above $46M and EPS exceeds $0.58, confirming sustained margin recovery post-acquisitionbullish
Debt reduction. Total debt declines meaningfully from the $854M FY2025 level, indicating free cash flow is being deployed to deleveragebullish
Volume deterioration. Quarterly revenue declines YoY or volumes turn negative, signaling that pricing alone cannot sustain growthbearish
Margin reversal. Operating margin contracts back toward breakeven or negative, undoing the Q3 FY2026 improvementbearish

Where this comes from: quarterly_results · earnings_surprises · news (GuruFocus, Fool) · peer_relative. Orin's read on NX; not advice.

Twelve months actual closes to 2026-09-23 · actual filings

Sept 25Nov 25Jan 26Mar 26May 26Jul 26

50-day average 200-day average · volume below

Largest holders · 13F Q2 2026

Money flow
FilerPositionOf fund
Ameriprise Financial$50.9M0.0% of fund
Tpg Gp A$38.3M0.8% of fund
Vanguard Capital Management$37.6M0.0% of fund
Vanguard Portfolio Management$36.4M0.0% of fund
State Street$33.6M0.0% of fund
Geode Capital Management$22.2M0.0% of fund

44 filers · quarter ended Q2 2026 · positions, not flows

Insiders, last 24 months: 95 Form 4 filings, net −$4.6M. Of the 50 on hand, 3 were open-market purchases and 2 sales— the rest are grants, option exercises and tax withholding.

Ask Orin about NX

its filings · its transcripts · its numbers

Orin answers questions about NX from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

Start 3 free days

Where it trades

· Industrials
MetricNowOwn medianSector
P/E20.0×44.5×
EV/EBITDA7.6×
P/S0.49×
P/B1.2×
What the price assumes

-3.5%

free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $0.1B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.

Against the companies it is compared to

median P/E 11.4× of 1 peers
CompanyMarket capP/EEV/EBITDAGrossNetROE
NXQuanex Building Products Corporation$911M20.0×7.6×22.7%2.4%6%
APOGApogee Enterprises, Inc.$768M11.4×6.6×23.3%4.9%13%
ASPNAspen Aerogels, Inc.$471M2.7%-62.4%-53%
LTBRLightbridge Corporation$236M0.1×0.0%0.0%-12%

The median is of the 1 peers listed above and nothing else — check it against the column. This company trades 74.7% above it. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.

What it has traded at

P/E by fiscal year
FY14 25.3×FY24 31.9×

What its sector has traded at

Industrials
FY14 173.5×FY26 32.7×

Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.

Every estimate on one scale

price $19.83
52-week range$11 – $23
At sector P/E (45×)$44

The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.